ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,866,197 | +22.5% | 261,753 | +48.2% | 0.00% | – |
| Q2 2023 | $2,339,243 | -69.5% | 176,680 | -68.6% | 0.00% | -100.0% |
| Q1 2023 | $7,665,342 | -53.7% | 563,214 | -33.5% | 0.00% | -50.0% |
| Q4 2022 | $16,539,155 | +4.1% | 846,859 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $15,885,000 | -26.8% | 833,894 | -20.8% | 0.00% | -33.3% |
| Q2 2022 | $21,697,000 | -16.0% | 1,053,234 | +31.3% | 0.00% | 0.0% |
| Q1 2022 | $25,820,000 | +238.1% | 802,370 | +389.3% | 0.00% | +200.0% |
| Q4 2021 | $7,636,000 | +80.5% | 163,999 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $4,230,000 | +80.5% | 156,608 | +71.4% | 0.00% | – |
| Q2 2021 | $2,344,000 | +46780.0% | 91,352 | +62469.9% | 0.00% | – |
| Q1 2021 | $5,000 | -98.3% | 146 | -98.3% | 0.00% | – |
| Q4 2020 | $286,000 | +384.7% | 8,453 | +255.9% | 0.00% | – |
| Q3 2020 | $59,000 | – | 2,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |